(Q47588716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

treatment-resistant depression

8 March 2020

main subject

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Trina E Chang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1

Cristina Cusin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

16

Maurizio Fava

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

14

David Mischoulon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

5

Paolo Cassano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Dawn Flosnik Ionescu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kara Jean Pavone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Oluwaseun Akeju

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Norman Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Matthias Eikermann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kelley Durham

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Christina Dording

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

David Soskin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

John Kelley

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Emery Neal Brown

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

55-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26893373%20AND%20SRC:MED&resulttype=core&format=json

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

General anesthesia and altered states of arousal: a systems neuroscience analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Serial infusions of low-dose ketamine for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867416631828